The Hain Celestial Group, Inc. (NASDAQ: HAIN), Ontario, CA – FDA Inspections
Inspection records and compliance data for The Hain Celestial Group, Inc. in Ontario, California. 2 FDA inspections on record, last inspected November 07, 2019. Publicly traded as NASDAQ: HAIN.
This profile covers The Hain Celestial Group, Inc. based in Ontario, California, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Unclassified
- 1
- Form 483s
- 0
- Warning letters
- 0
First inspected February 27, 2018. Last inspected November 7, 2019.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| November 7, 2019 | NAI | Human Drugs · Drug Quality Assurance | 1110843 |
| February 27, 2018 | Not classified | Foods & Cosmetics | 1042682 |
No Form 483s, Warning Letters or EIRs on record.
Companies with similar regulatory profiles, compliance history, and operations.
Name
The Hain Celestial Group, Inc.
Stock ticker
HAIN
Exchange
NASDAQ
Share price
$0.14
Market cap
$12.4M
Price as of
November 6, 2026
FEI Number
3003742698
Address
5140 Santa Ana St, Ontario, California 91761, United States
Country
United States
ID: f3a30e8e-d2bb-4cd6-825b-a17a92dc62a6